Novo Nordisk Breakfast Symposium: Why Weight? Transforming weight management with Wegovy® (semaglutide 2.4 mg)*
Tracks
Arrhythmia / EP
Mechanisms and Preclinical Discovery
Clinical / Surgical
Heart Failure
Imaging
Multidisciplinary
Paediatrics / Adult Congenital
Other
EHJ / HLC
ANZET
Friday, August 2, 2024 |
7:15 AM - 8:15 AM |
Meeting Room 7 |
Details
The global obesity epidemic is well established.1 In Australia, approximately 13 million adults were living with overweight or obesity
in 2022.2 Obesity contributes directly to incident cardiovascular risk factors, including dyslipidemia, hypertension, type 2 diabetes
and sleep disorders1 and can lead to the development of CVD and CVD mortality independently of other cardiovascular risk factors.1,3
Hear from a panel of local and international experts including Professor Pam Taub, Cardiologist and Professor of Medicine
at UC San Diego, alongside Associate Professor Melissa Leung and Professor Gerald Watts. Together they will discuss patient
cases and share their clinical experience and practical tips on optimising the use of Wegovy® (semaglutide 2.4 mg)* for managing
overweight or obesity in patients with CVD.
Speaker
Prof Melissa Leung
Cardiologist
Liverpool Hospital
Why Weight? Transforming weight management with Wegovy® (semaglutide 2.4 mg)*
7:15 AM - 8:15 AMBiography
Cardiologist; Clinical Trialist; Biostatistician; Director of Cardiac Imaging
& Deputy Director of Clinical Trials at Liverpool Hospital, Sydney.
Prof Pam Taub
Cardiologist / Professor of Medicine
University of California San Diego
Why Weight? Transforming weight management with Wegovy® (semaglutide 2.4 mg)*
7:15 AM - 8:15 AMBiography
Cardiologist; Professor of Medicine, UC San Diego; Founding Director,
STEP Family Foundation Cardiac Rehabilitation and Wellness Center.
Prof Gerald F Watts
Consultant Physician/Professor
Royal Perth Hospital / University of Western Australia
Why Weight? Transforming weight management with Wegovy® (semaglutide 2.4 mg)*
7:15 AM - 8:15 AMBiography
Head, Cardiometabolic Service, Department of Cardiology and Internal
Medicine at Royal Perth Hospital; Senior Consultant Physician; Chair,
Familial Hypercholesterolemia Australasia Network.